{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:27:23Z","timestamp":1789198043959,"version":"build-2803163510"},"reference-count":111,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism Reviews"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/03602532.2026.2641226","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:51:39Z","timestamp":1772761899000},"page":"192-226","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["A critical review of analytical tools for the detection of spironolactone and its metabolites"],"prefix":"10.1080","volume":"58","author":[{"given":"Hemn A. H.","family":"Barzani","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Science, College of Health Science, Lebanese French University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebaz Anwar","family":"Omer","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Sciences and Health, Koya University","place":["Koya, F.R. Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalamala Ibrahim Salih","family":"Barzani","sequence":"additional","affiliation":[{"name":"Department of Nursing, Mergasor Technical Institute, Erbil Polytechnic University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad Mahmood","family":"Qadir","sequence":"additional","affiliation":[{"name":"Department of General Science, College of Basic Education, University of Halabja","place":["Halabja, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanco Hassan","family":"Jawhar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Health Sciences, Hawler Medical University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seerwan Hamadameen","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, College of Health Science, Lebanese French University","place":["Erbil, Iraq"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshyar Saadi","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Science, Van Yuzuncu Yil University","place":["Van, Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639049809085594"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/00032710701746832"},{"key":"e_1_3_3_4_1","first-page":"261","volume-title":"Analytical profiles of drug substances and excipients","author":"Al-Hadiya BM","year":"2002","unstructured":"Al-Hadiya BM, Belal F, Asiri YA, Gubara OA. 2002. Spironolactone. In: Analytical profiles of drug substances and excipients. Vol. 29. Elsevier. p 261\u2013320."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-023-31217-w"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.29328\/journal.aac.1001026"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.5599\/admet.2357"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/28.3.123"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44211-022-00190-8"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.2116\/analsci.26.755"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2298\/JSC240221090B"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2025.111995"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2025.2511141"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diamond.2022.109658"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01772348"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1515\/pthp-2018-0011"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(93)80179-5"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200001000-00004"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0642-8"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-022-05267-9"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vibspec.2018.12.006"},{"issue":"10","key":"e_1_3_3_22_1","first-page":"3999","article-title":"Development and validation of ratio derivative spectrophotometric for simultaneous estimation of metolazone and spironolactone in pharmaceutical dosage form","volume":"3","author":"Chaudhary A","year":"2012","unstructured":"Chaudhary A, Vadalia K, Thummer P. 2012. Development and validation of ratio derivative spectrophotometric for simultaneous estimation of metolazone and spironolactone in pharmaceutical dosage form. Int J Pharm Sci Res. 3(10):3999.","journal-title":"Int J Pharm Sci Res"},{"issue":"8","key":"e_1_3_3_23_1","first-page":"2866","article-title":"RP-HPLC method for the simultaneous estimation of losartan and spironolactone in tablet dosage form","volume":"11","author":"Chaure PP","year":"2019","unstructured":"Chaure PP, Sigh S, Shariff A, Wagh VH, Tandale SD. 2019. RP-HPLC method for the simultaneous estimation of losartan and spironolactone in tablet dosage form. J Pharm Sci Res. 11(8):2866\u20132871.","journal-title":"J Pharm Sci Res"},{"issue":"5","key":"e_1_3_3_24_1","first-page":"212","article-title":"Method development and validation of spectrophotometric and RP-HPLC methods for simultaneous estimation of spironolactone and furosemide in bulk and combined tablet dosage forms","volume":"34","author":"Chavan RR","year":"2021","unstructured":"Chavan RR, Bhinge SD, Bhutkar MA, Randive DS, Salunkhe VR. 2021. Method development and validation of spectrophotometric and RP-HPLC methods for simultaneous estimation of spironolactone and furosemide in bulk and combined tablet dosage forms. Anal Sci Technol. 34(5):212\u2013224.","journal-title":"Anal Sci Technol"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.09.003"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.2174\/157341111794815048"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2019.06.033"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquatox.2017.01.001"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1556\/AChrom.24.2012.1.2"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1081\/SL-120024583"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.farmac.2003.07.005"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jms.1006"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1556\/1326.2020.00790"},{"issue":"4","key":"e_1_3_3_34_1","first-page":"35","article-title":"Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography","volume":"63","author":"Ecaterina M","year":"2020","unstructured":"Ecaterina M, Martin S, Livia U. 2020. Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography. Moldovan Med J. 63(4):35\u201342.","journal-title":"Moldovan Med J"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2012.10.001"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/separations10060351"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902023e21626"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4656"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-022-05163-2"},{"issue":"4","key":"e_1_3_3_40_1","first-page":"1106","article-title":"High performance thin layer chromatographic determination of spironolactone and torsemide in combined tablet dosage form","volume":"3","author":"Gaikwad NV","year":"2010","unstructured":"Gaikwad NV, Deshpande PB, Gandhi SV, Khandagale KK. 2010. High performance thin layer chromatographic determination of spironolactone and torsemide in combined tablet dosage form. Res J Pharm Technol. 3(4):1106\u20131108.","journal-title":"Res J Pharm Technol"},{"issue":"03","key":"e_1_3_3_41_1","first-page":"4273","article-title":"Development and validation of RP-HPLC method for estimation of dapagliflozin and spironolactone in synthetic mixture","volume":"53","author":"Gajjar K","year":"2024","unstructured":"Gajjar K, Tiwari N, Patani P. 2024. Development and validation of RP-HPLC method for estimation of dapagliflozin and spironolactone in synthetic mixture. Cuestiones Fisioterapia. 53(03):4273\u20134306.","journal-title":"Cuestiones Fisioterapia"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202100452"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.125"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/chrsci\/49.2.129"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1039\/b000666l"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(94)00241-x"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107425"},{"issue":"10","key":"e_1_3_3_48_1","first-page":"448","article-title":"A new stability indicating UPLC method development and validation for the simultaneous estimation of metolazone and spironolactone in bulk and in its pharmaceutical formulations","volume":"6","author":"Ismail Y","year":"2014","unstructured":"Ismail Y, Chandrasekhar K, Gunasekaran V. 2014. A new stability indicating UPLC method development and validation for the simultaneous estimation of metolazone and spironolactone in bulk and in its pharmaceutical formulations. Int J Pharm Pharma Sci. 6(10):448\u2013452.","journal-title":"Int J Pharm Pharma Sci"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3329\/bjsir.v51i4.30450"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052213"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0731-7085(96)01767-0"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112257"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9673(97)01167-9"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.33137\/jns.v2i1.35920"},{"key":"e_1_3_3_55_1","first-page":"77","article-title":"Analysis of carvedilol and spironolactone in pharmaceutical dosage form and dissolution samples by simultaneous equation method and derivative method","volume":"2","author":"Kundu P","year":"2016","unstructured":"Kundu P et al. 2016. Analysis of carvedilol and spironolactone in pharmaceutical dosage form and dissolution samples by simultaneous equation method and derivative method. Biopharm J. 2:77\u201386.","journal-title":"Biopharm J"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-023-03599-w"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-015-0197-9"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201600255"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2023.2202260"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902022e19487"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1134\/S1061934824700291"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/00032719808005267"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-9140(98)00357-9"},{"issue":"3","key":"e_1_3_3_64_1","first-page":"144","article-title":"Development and validation of RP-HPLC method for simultaneous estimation of furosemide and spironolactone in their combined tablet dosage form","volume":"2","author":"Maulik B","year":"2012","unstructured":"Maulik B, Ketan D, Shital F. 2012. Development and validation of RP-HPLC method for simultaneous estimation of furosemide and spironolactone in their combined tablet dosage form. J Pharm Sci Bioscientific Res. 2(3):144\u2013147.","journal-title":"J Pharm Sci Bioscientific Res"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.52645\/MJHS.2024.4.06"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28010328"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8873003"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4304"},{"issue":"1","key":"e_1_3_3_69_1","first-page":"20","article-title":"Development and validation of HPTLC method for simultaneous estimation of metolazone and spironolactone in bulk drug and pharmaceutical dosage form","volume":"4","author":"Nazareth C","year":"2014","unstructured":"Nazareth C, Shivakumar B, Reddy P, Gurupadayya B. 2014. Development and validation of HPTLC method for simultaneous estimation of metolazone and spironolactone in bulk drug and pharmaceutical dosage form. IOSR J Pharm. 4(1):20\u201325.","journal-title":"IOSR J Pharm"},{"issue":"2","key":"e_1_3_3_70_1","first-page":"235","article-title":"Lipophilicity assessment of spironolactone by means of reversed phase liquid chromatography and by newly developed calculation procedures","volume":"72","author":"Newly B.","year":"2015","unstructured":"Newly B. 2015. Lipophilicity assessment of spironolactone by means of reversed phase liquid chromatography and by newly developed calculation procedures. Acta Pol Pharm. 72(2):235.","journal-title":"Acta Pol Pharm"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2007.10.025"},{"issue":"6","key":"e_1_3_3_72_1","first-page":"1496","article-title":"Analytical method development and validation of simultaneous estimation of metolazone and spironolactone in bulk and pharmaceutical dosage form by RP-HPLC","volume":"2","author":"Pallavi G","year":"2014","unstructured":"Pallavi G, Kumar AR. 2014. Analytical method development and validation of simultaneous estimation of metolazone and spironolactone in bulk and pharmaceutical dosage form by RP-HPLC. Indian J Res Pharm Biotechnol. 2(6):1496.","journal-title":"Indian J Res Pharm Biotechnol"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1556\/1006.2016.29.5.9"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.25135\/jcm.94.2304.2769"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.53555\/AJBR.v27i3.1736"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.5958\/2394-2797.2016.00024.1"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639049109051604"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.52711\/2231-5713.2023.00029"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202300174"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.56431\/p-vo6l6t"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bms062"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1984-82502016000400005"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.18034\/abcjar.v12i2.783"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1177\/1074248413497257"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573412913666161227155922"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2021.123046"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.02.017"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.47890\/jcsce\/2020\/mahmoudm\/10082112"},{"issue":"4","key":"e_1_3_3_89_1","first-page":"427","article-title":"Development and validation of isocratic reversed-phase HPLC method for simultaneous estimation of torsemide and spironolactone in bulk and pharmaceutical combined tablet dosage form","volume":"2010","author":"Sharma S","year":"2010","unstructured":"Sharma S, Sharma M, Chaturvedi S. 2010. Development and validation of isocratic reversed-phase HPLC method for simultaneous estimation of torsemide and spironolactone in bulk and pharmaceutical combined tablet dosage form. Optoelectron Adv Mater Rapid Commun. 2010(4):427\u2013430.","journal-title":"Optoelectron Adv Mater Rapid Commun"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.110652"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-005-2345-1"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2017.12.007"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.03.004"},{"key":"e_1_3_3_94_1","unstructured":"Sravani Datta K Reddy CS Smaigdhini C Sreelatha G. 2024. Stability indicating UPLC method development and validation of furosemide and spironolactone in bulk dosage form. 9(2):14\u201321."},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.17344\/acsi.2014.1262"},{"issue":"1","key":"e_1_3_3_96_1","first-page":"23","article-title":"Dissolution tests of hydrochlorothiazide and spironolactone in commercial tablets: comparison of spectroscopic and high performance liquid chromatography methods","volume":"32","author":"S\u00fck\u00fcroglu M","year":"2007","unstructured":"S\u00fck\u00fcroglu M, Tirnaksiz F, Atay O. 2007. Dissolution tests of hydrochlorothiazide and spironolactone in commercial tablets: comparison of spectroscopic and high performance liquid chromatography methods. Fabad J Pharm Sci. 32(1):23.","journal-title":"Fabad J Pharm Sci"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1080\/10934529.2015.1047668"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01827-x"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1002\/jccs.200800149"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-017-0255-4"},{"issue":"2","key":"e_1_3_3_101_1","first-page":"53","article-title":"Quantitative determination of hydrochlorothiazide and spironolactone in tablets by spectrophotometric and HPLC methods","volume":"5","author":"Tekerek E","year":"2008","unstructured":"Tekerek E, Sukuroglu M, Atay O. 2008. Quantitative determination of hydrochlorothiazide and spironolactone in tablets by spectrophotometric and HPLC methods. Turk J Pharm Sci. 5(2):53\u201366.","journal-title":"Turk J Pharm Sci"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6AY00478D"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.13005\/bbra\/3125"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80097-a"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.5562\/cca1761"},{"issue":"5","key":"e_1_3_3_106_1","first-page":"2648","article-title":"Micellar high performance liquid chromatographic determination of furosemide and spironolactone in combined dosage forms","volume":"5","author":"Walash M","year":"2012","unstructured":"Walash M, El-Enany N, Eid M, Fathy M. 2012. Micellar high performance liquid chromatographic determination of furosemide and spironolactone in combined dosage forms. Appl Hum Plasma J Pharm Res. 5(5):2648\u20132656.","journal-title":"Appl Hum Plasma J Pharm Res"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3ay41110a"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011281"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296479"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051065"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826076.2020.1731694"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107812"}],"container-title":["Drug Metabolism Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03602532.2026.2641226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:08:10Z","timestamp":1777842490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03602532.2026.2641226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/03602532.2026.2641226"],"URL":"https:\/\/doi.org\/10.1080\/03602532.2026.2641226","relation":{},"ISSN":["0360-2532","1097-9883"],"issn-type":[{"value":"0360-2532","type":"print"},{"value":"1097-9883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}